
Drug-price reforms need not affect research on rare diseases – or the Canadians who have them
Aug 26 2019- POSTED BY Loknath Das
On Aug. 9, the Patented Medicine Prices Review Board of Canada announced new drug-pricing regulations for new patented medicines that […]
Read More